High Vista Strategies LLC Moon Lake Immunotherapeutics Transaction History
High Vista Strategies LLC
- $242 Million
- Q4 2024
A detailed history of High Vista Strategies LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, High Vista Strategies LLC holds 43,541 shares of MLTX stock, worth $1.64 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
43,541
Previous 43,541
-0.0%
Holding current value
$1.64 Million
Previous $2.2 Million
5.38%
% of portfolio
0.95%
Previous 0.86%
Shares
5 transactions
Others Institutions Holding MLTX
# of Institutions
137Shares Held
58.1MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$745 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$321 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$126 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$105 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$82.5 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.39B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...